10-Year Oncologic Outcomes After Laparoscopic and Open Partial Nephrectomy

No AccessJournal of UrologyAdult Urology1 Jul 201310-Year Oncologic Outcomes After Laparoscopic and Open Partial Nephrectomy Brian R. Lane, Steven C. Campbell, and Inderbir S. Gill Brian R. LaneBrian R. Lane Division of Urology, Spectrum Health and Michigan State University College of Human Medicine, Grand Rapids, Michigan , Steven C. CampbellSteven C. Campbell Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, Ohio , and Inderbir S. GillInderbir S. Gill Institute of Urology, University of Southern California, Los Angeles, California View All Author Informationhttps://doi.org/10.1016/j.juro.2012.12.102AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract Purpose: Open partial nephrectomy has proven long-term oncologic efficacy. Laparoscopic partial nephrectomy outcomes at 5 to 7 years of followup appear comparable to those of the open approach. We present the 10-year outcomes of patients who underwent laparoscopic or open partial nephrectomy for a single clinical stage cT1 7 cm or less renal cortical tumor. Materials and Methods: Of 1,541 patients treated with partial nephrectomy for a single cT1 tumor between 1999 and 2007 with a minimum 5-year followup, an actual followup of 10 years or greater was available in 45 and 254 after laparoscopic and open partial nephrectomy, respectively. Results: Median followup after laparoscopic and open surgery was 6.6 and 7.8 years, respectively. At 10 years the overall survival rate was 77.2%. The metastasis-free survival rate was 95.2% and 90.0% after partial nephrectomy for clinical T1a and T1b renal cell carcinoma, respectively (p <0.0001). Baseline differences between patients treated with laparoscopic and open partial nephrectomy accounted for most observed differences between the cohorts. The median glomerular filtration rate decrease was 16.9% after the laparoscopic approach and 14.1% after the open approach (p = 0.5). On multivariable analysis predictors of all cause mortality included advancing age (HR 1.52/10 years, p <0.0001), comorbidity (HR 1.33/1 U, p <0.0001), absolute indication (HR 2.25, p = 0.003) and predicted recurrence-free survival (HR 1.58/10% increased risk, p = 0.004) but not laparoscopic vs open operative approach (p = 0.13). Similarly, predictors of metastasis included absolute indication (HR 4.35, p <0.0001) and predicted recurrence-free survival (HR 2.67, p <0.0001) but not operative approach (p = 0.42). Conclusions: The 10-year outcomes of laparoscopic nephrectomy and open partial nephrectomy are excellent in carefully selected patients with limited risk of recurrence for cT1 renal cortical tumors. Overall survival at 10 years is mediated by patient factors such as age, comorbidity and operative indication, and by cancer factors such as predicted recurrence-free survival but not by the choice of operative technique, which depends on surgeon preference and experience. References 1 : Guideline for management of the clinical T1 renal mass. J Urol2009; 182: 1271. Link, Google Scholar 2 : Partial nephrectomy for unilateral renal carcinoma and a normal contralateral kidney: 10-year followup. J Urol1999; 161: 33. Link, Google Scholar 3 : Long-term results of nephron sparing surgery for localized renal cell carcinoma: 10-year followup. J Urol2000; 163: 442. Link, Google Scholar 4 : Trends in renal surgery: robotic technology is associated with increased utilization of partial nephrectomy. J Urol2013; 189: 1229. Link, Google Scholar 5 : Five year outcomes of laparoscopic partial nephrectomy. J Urol2007; 177: 70. Link, Google Scholar 6 : Laparoscopic partial nephrectomy: evaluation of long-term oncological outcome. J Urol2004; 172: 871. Link, Google Scholar 7 : 7-Year oncological outcomes after laparoscopic and open partial nephrectomy. J Urol2010; 183: 473. Link, Google Scholar 8 : Laparoscopic partial nephrectomy for renal tumor: duplicating open surgical techniques. J Urol2002; 167: 469. Link, Google Scholar 9 : Renal-sparing surgery for renal cell carcinoma. Urol Clin North Am1993; 20: 277. Google Scholar 10 : A new equation to estimate glomerular filtration rate. Ann Intern Med2009; 150: 604. Google Scholar 11 : K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis2002; 39: S1. Google Scholar 12 : Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int2005; 67: 2089. Google Scholar 13 : A postoperative prognostic nomogram for renal cell carcinoma. J Urol2001; 166: 63. Link, Google Scholar 14 : Renal tumors. In: Campbell-Walsh Urology. Edited by . Philadelphia: Saunders/Elsevier2007. chap 47. Google Scholar 15 : Trends in renal tumor surgery delivery within the United States. Cancer2010; 116: 2316. Google Scholar 16 : Partial nephrectomy versus radical nephrectomy in patients with small renal tumors—is there a difference in mortality and cardiovascular outcomes?. J Urol2009; 181: 55. Link, Google Scholar 17 : Radical nephrectomy for pT1a renal masses may be associated with decreased overall survival compared with partial nephrectomy. J Urol2008; 179: 468. Link, Google Scholar 18 : Matched comparison of radical nephrectomy vs nephron-sparing surgery in patients with unilateral renal cell carcinoma and a normal contralateral kidney. Mayo Clin Proc2000; 75: 1236. Google Scholar 19 : Surgical management of renal tumors 4 cm. or less in a contemporary cohort. J Urol2000; 163: 730. Link, Google Scholar 20 : Natural history of chronic renal insufficiency after partial and radical nephrectomy. Urology2002; 59: 816. Google Scholar 21 : A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma. Eur Urol2011; 59: 543. Google Scholar 22 : Long-term survival following partial vs radical nephrectomy among older patients with early-stage kidney cancer. JAMA2012; 307: 1629. Google Scholar © 2013 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetailsCited ByAuffenberg G, Curry M, Gennarelli R, Blum K, Elkin E and Russo P (2020) Comparison of Cancer Specific Outcomes following Minimally Invasive and Open Surgical Resection of Early Stage Kidney Cancer from a National Cancer RegistryJournal of Urology, VOL. 203, NO. 6, (1094-1100), Online publication date: 1-Jun-2020.Snarskis C, Calaway A, Wang L, Gondim D, Hughes I, Idrees M, Kliethermes S, Maniar V, Picken M, Boris R and Gupta G (2018) Standardized Reporting of Microscopic Renal Tumor Margins: Introduction of the Renal Tumor Capsule Invasion Scoring SystemJournal of Urology, VOL. 197, NO. 1, (23-30), Online publication date: 1-Jan-2017.Lobo J, Nelson M, Nandanan N and Krupski T (2018) Comparison of Renal Cell Carcinoma Surveillance Guidelines: Competing Trade-OffsJournal of Urology, VOL. 195, NO. 6, (1664-1670), Online publication date: 1-Jun-2016.Laguna M (2018) Re: Five-Year Oncologic Outcomes after Transperitoneal Robotic Partial Nephrectomy for Renal Cell CarcinomaJournal of Urology, VOL. 196, NO. 5, (1398-1398), Online publication date: 1-Nov-2016.Ploussard G, Haddad R, Loutochin O, Bera R, Cabrera T, Malibari N, Scarlata E, Derbekyan V, Bladou F and Anidjar M (2018) A Combination of Hemostatic Agents May Safely Replace Deep Medullary Suture during Laparoscopic Partial Nephrectomy in a Pig ModelJournal of Urology, VOL. 193, NO. 1, (318-324), Online publication date: 1-Jan-2015.Klatte T, Shariat S and Remzi M (2018) Systematic Review and Meta-Analysis of Perioperative and Oncologic Outcomes of Laparoscopic Cryoablation Versus Laparoscopic Partial Nephrectomy for the Treatment of Small Renal TumorsJournal of Urology, VOL. 191, NO. 5, (1209-1217), Online publication date: 1-May-2014. Volume 190Issue 1July 2013Page: 44-49 Advertisement Copyright & Permissions© 2013 by American Urological Association Education and Research, Inc.Keywordslaparoscopyoutcome assessment (health care)kidneynephrectomycarcinoma, renal cellMetricsAuthor Information Brian R. Lane Division of Urology, Spectrum Health and Michigan State University College of Human Medicine, Grand Rapids, Michigan More articles by this author Steven C. Campbell Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, Ohio More articles by this author Inderbir S. Gill Institute of Urology, University of Southern California, Los Angeles, California More articles by this author Expand All Advertisement PDF DownloadLoading ...